BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2920767)

  • 1. Clinical and radiological correlation of retroperitoneal metastasis from nonseminomatous testicular cancer treated with chemotherapy.
    Dexeus FH; Shirkhoda A; Logothetis CJ; Chong C; Sella A; Ogden S; Swanson D
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):35-43. PubMed ID: 2920767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.
    Fosså SD; Ous S; Lien HH; Stenwig AE
    J Urol; 1989 Mar; 141(3):557-9. PubMed ID: 2918591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
    Herr HW; Toner GC; Geller NL; Bosl GJ
    Eur Urol; 1991; 19(1):1-5. PubMed ID: 1848821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology.
    Stomper PC; Jochelson MS; Garnick MB; Richie JP
    AJR Am J Roentgenol; 1985 Oct; 145(4):743-6. PubMed ID: 3875994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the residual retroperitoneal mass after chemotherapy for advanced seminoma.
    Ellison MF; Mostofi FK; Flanigan RC
    J Urol; 1988 Sep; 140(3):618-20. PubMed ID: 3411688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.
    Steyerberg EW; Gerl A; Fossá SD; Sleijfer DT; de Wit R; Kirkels WJ; Schmeller N; Clemm C; Habbema JD; Keizer HJ
    J Clin Oncol; 1998 Jan; 16(1):269-74. PubMed ID: 9440752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
    Steyerberg EW; Keizer HJ; Sleijfer DT; Fossâ SD; Bajorin DF; Gerl A; de Wit R; Kirkels WJ; Koops HS; Habbema JD
    Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer.
    Vugrin D; Whitmore WF
    Cancer; 1985 May; 55(9):1874-8. PubMed ID: 4038913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses.
    Hendry WF; Norman AR; Dearnaley DP; Fisher C; Nicholls J; Huddart RA; Horwich A
    Cancer; 2002 Mar; 94(6):1668-76. PubMed ID: 11920527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
    Fosså SD; Qvist H; Stenwig AE; Lien HH; Ous S; Giercksky KE
    J Clin Oncol; 1992 Apr; 10(4):569-73. PubMed ID: 1312586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
    Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
    Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retroperitoneal recurrence of non-seminomatous testicular tumors: computerized tomography findings before retroperitoneal lymph node excision].
    Hosten N; Stroszczynski C; Rick O; Lemke M; Felix R
    Rofo; 1999 Jan; 170(1):61-5. PubMed ID: 10071646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic retroperitoneal lymph node dissection after chemotherapy.
    Palese MA; Su LM; Kavoussi LR
    Urology; 2002 Jul; 60(1):130-4. PubMed ID: 12100938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.
    Leão R; Nayan M; Punjani N; Jewett MAS; Fadaak K; Garisto J; Lewin J; Atenafu EG; Sweet J; Anson-Cartwright L; Boström P; Chung P; Warde P; Bedard PL; Bagrodia A; Freifeld Y; Power N; Winquist E; Hamilton RJ
    Eur Urol Focus; 2018 Dec; 4(6):995-1001. PubMed ID: 29428550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.
    Oldenburg J; Alfsen GC; Lien HH; Aass N; Waehre H; Fossa SD
    J Clin Oncol; 2003 Sep; 21(17):3310-7. PubMed ID: 12947067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?
    Stomper PC; Kalish LA; Garnick MB; Richie JP; Kantoff PW
    Radiology; 1991 Sep; 180(3):711-4. PubMed ID: 1651526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.